F Cantrell
Pediatrics · Marietta, GANPI 1881641793
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $110,063 of the $129,207 with a category attached, or 85.2%. Supernus Pharmaceuticals, Inc. accounts for 95.7% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $43,617, more than ten times the $4,108 reported in 2019. Among pediatrics clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 493 payments — averaging $262.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$124K
- Corium, LLC$3K
- Ironshore Pharmaceuticals Inc.$829
- Neos Therapeutics, LP$601
- Tris Pharma Inc$347
- Takeda Pharmaceuticals U.S.A., Inc.$272
- plus $867 from 13 others
What the payments were for
- Consulting fees$1,8001%
- Speaking & faculty fees$110,06385%
- Travel & lodging$9,1287%
- Food & beverage$8,2166%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 249 | $123,595 |
| Corium, LLC | 55 | $2,697 |
| Ironshore Pharmaceuticals Inc. | 37 | $829 |
| Neos Therapeutics, LP | 61 | $601 |
| Tris Pharma Inc | 20 | $347 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $272 |
| Vertical Pharmaceuticals, LLC | 14 | $225 |
| Collegium Pharmaceutical, Inc. | 10 | $166 |
| Cranial Technologies, Inc | 8 | $124 |
| Noven Therapeutics, LLC | 6 | $111 |
| Avion Pharmaceuticals | 3 | $56 |
| Merck | 3 | $44 |
| Pfizer | 2 | $43 |
| Genentech USA, Inc. | 1 | $21 |
| Noven Pharmaceuticals, Inc. | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| Aytu Biopharma, Inc. | 2 | $14 |
| Adlon Therapeutics L.p. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$110,160
- Azstarys$1,928
- Jornay PM 20mg capsules (Bottle of 100)$329
How this compares
$129,207 in reported general payments places this provider in the 95th percentile of 2,111 pediatrics providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluoxetine Hcl | 11 | $53 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Marietta
- Daniel HeineMarietta$4K
- Daniel SaadeMarietta$3K
- Amir AshrafiAtlanta$563K
- Sandra ArmsteadLithonia$424K
- Satheesh ChonatAtlanta$147K
- Karen ZimowskiAtlanta$139K
- Iyabode Akinsanya-BeysolowAtlanta$103K
- Lauren MiddlebrooksAtlanta$71K
- Rebecca EmoryAtlanta$40K
- Mark GriffithsAtlanta$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.